BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is being made pursuant to a shelf registration statement on Form S-3.
Net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Public Offering Announcement
BioSig Technologies, Inc. is planning a public offering of common stock.
Use of Proceeds
The net proceeds will be utilized for purchasing gold bullion, working capital, and general corporate purposes.
Offering Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering is subject to market conditions, with uncertainties regarding timing, size, and terms.
- Investors are advised to read all relevant documents before investing in the offering.
Investors should carefully consider the information provided and the company's investment policy before participating in the offering.